Citation 83739

DUAN,HQ: TAKAISHI,Y: MOMOTA,H: OHMOTO,Y: TAKI,T: JIA,YF: LI,D:. (1999). IMMUNOSUPPRESSIVE DITERPENOIDS FROM TRIPTERYGIUM WILFORDII.. 62(11)

Citation Details

Title	IMMUNOSUPPRESSIVE DITERPENOIDS FROM TRIPTERYGIUM WILFORDII.
Authors	DUAN,HQ: TAKAISHI,Y: MOMOTA,H: OHMOTO,Y: TAKI,T: JIA,YF: LI,D:
Year	1999
Volume	62
Issue	11

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Tripterygium wilfordii (CELASTRACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE L	None
2	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE M	None
3	IMMUNOSUPPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE M	ACTIVE
4	IMMUNOSUPPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE M	ACTIVE
5	IMMUNOSUPPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE M	ACTIVE
6	IMMUNOSUPPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE M	WEAK ACTIVITY
7	IMMUNOSUPPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE M	INACTIVE
8	IMMUNOSUPPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE M	WEAK ACTIVITY
9	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE N	None
10	IMMUNOSUPPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE N	WEAK ACTIVITY
11	IMMUNOSUPPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE N	WEAK ACTIVITY
12	IMMUNOSUPPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE N	ACTIVE
13	IMMUNOSUPPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE N	INACTIVE
14	IMMUNOSUPPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE N	ACTIVE
15	IMMUNOSUPPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TRIPTOBENZENE N	ACTIVE
16	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED	TRIPTONEDIOL	None
17	Not specified	ISOLATION AND IDENTIFICATION OF	TRIPTOQUINONE C	None
18	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTOQUINONE C	INACTIVE
19	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTOQUINONE C	INACTIVE
20	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTOQUINONE C	WEAK ACTIVITY
21	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTOQUINONE C	ACTIVE
22	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTOQUINONE C	ACTIVE
23	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTOQUINONE C	STRONG ACTIVITY
24	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED	KAURAN-19-OIC ACID,16-ALPHA-HYDROXY: (-):	None
25	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED	KAURAN-19-OIC ACID,16-ALPHA: 17-HYDROXY: (-):	None
26	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-ALPHA: 17-HYDROXY: (-):	INACTIVE
27	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-ALPHA: 17-HYDROXY: (-):	WEAK ACTIVITY
28	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-ALPHA: 17-HYDROXY: (-):	INACTIVE
29	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-ALPHA: 17-HYDROXY: (-):	ACTIVE
30	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-ALPHA: 17-HYDROXY: (-):	WEAK ACTIVITY
31	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-ALPHA: 17-HYDROXY: (-):	WEAK ACTIVITY
32	Not specified	ISOLATION AND IDENTIFICATION OF	TRIPTOBENZENE H	None
33	Not specified	ISOLATION AND IDENTIFICATION OF	TRIPTERIFORDIN	None
34	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTERIFORDIN	STRONG ACTIVITY
35	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTERIFORDIN	STRONG ACTIVITY
36	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTERIFORDIN	STRONG ACTIVITY
37	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTERIFORDIN	STRONG ACTIVITY
38	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTERIFORDIN	STRONG ACTIVITY
39	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	TRIPTERIFORDIN	STRONG ACTIVITY
40	Not specified	ISOLATION AND IDENTIFICATION OF	MANOYL OXIDE-18-OIC ACID,13-EPI:	None
41	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	MANOYL OXIDE-18-OIC ACID,13-EPI:	ACTIVE
42	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	MANOYL OXIDE-18-OIC ACID,13-EPI:	ACTIVE
43	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	MANOYL OXIDE-18-OIC ACID,13-EPI:	WEAK ACTIVITY
44	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	MANOYL OXIDE-18-OIC ACID,13-EPI:	STRONG ACTIVITY
45	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	MANOYL OXIDE-18-OIC ACID,13-EPI:	STRONG ACTIVITY
46	IMMUNOSUPPRESSANT ACTIVITY	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITRO	MANOYL OXIDE-18-OIC ACID,13-EPI:	STRONG ACTIVITY
47	Not specified	ISOLATION AND IDENTIFICATION OF	TRIPTOQUINONE ATRIPTOQUINONE BHINOKIOLTRIPTININ BTRIPTOBENZENE ATRIPTOTIN BKAURANE,16-ALPHA-19-DIHYDROXY: ENT:	None

Citation 83739

Citation Details

Summary

Organisms and Their Experiments (1)

Tripterygium wilfordii (CELASTRACEAE)

Show SPARQL Queries (1)

Query 1